Open AccessDelivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
Author(s) -
Wade M. Cooper,
Sutapa Ray,
Sheena K. Aurora,
Stephen B. Shrewsbury,
Christopher C. Fuller,
Greg Davies,
John Hoekman
Publication year - 2022
Publication title -
journal of aerosol medicine and pulmonary drug delivery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.678
H-Index - 68
eISSN - 1941-2703
pISSN - 1941-2711
DOI - 10.1089/jamp.2022.0005
Subject(s) - dihydroergotamine , medicine , sumatriptan , nasal administration , nasal cavity , onset of action , anesthesia , nasal spray , pharmacology , drug , drug delivery , migraine , pharmacokinetics , mucociliary clearance , absorption (acoustics) , nose , bioavailability , surgery , agonist , chemistry , physics , receptor , organic chemistry , lung , acoustics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom